Loading search results
Sponsor study identifier
Secondary identifiers
observational
3,795
1 country
1
Study Start
November 7, 1995
Actual (reported)Primary Completion
May 31, 2020
Actual (reported)Study Completion
June 5, 2020
Actual (reported)Nasopharyngeal carcinoma is a rare tumor among Caucasians which occurs with high incidence among individuals of Chinese descent. The disease is believed to have a multifactorial etiology with genetic, viral, and other environmental factors being involved. Little is known, however, about the genetic component of this disease. We have recently completed subject recruitment for a case-control study of NPC in Taiwan. Using information obtained from the NPC cases recruited into this NCI-sponsored case-control study as well as from a parallel cross-sectional study conducted by our Taiwanese collaborators, we have been able to identify 120-150 families with multiple family members affected with NPC. The purpose of the study described herein is to determine the role of inherited genetic factors in the etiology of NPC and to examine the effect of these genetic susceptibility factors on risk associated with environmental exposures. Families will initially be contacted via the proband who previously participated in our case-control and cross-sectional studies. Subsequently, informative family members will be asked to visit the study clinic to participate in the study. A family history questionnaire will be administered to the proband from each of the families selected for study. In addition, a risk factor questionnaire will be administered to all participating family members, and 30-40 ml of blood and an oral sample will be obtained from each study participant. Additional study components include medical record review to verify the diagnosis of NPC, retrieval of tumor tissue blocks as a source of DNA for study, and clinical exams on a sample of unaffected individuals to exclude the possibility of prevalent, undetected disease among family members. Oral and laryngeal cancer families will also be recruited in a manner similar to that described for NPC families, in an attempt to elucidate genetic factors linked to the development of these two cancers....
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 5, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 7, 1995
Actual (reported)June 19, 2006
Actual (reported)June 21, 2006
Actual (reported)May 31, 2020
Actual (reported)June 5, 2020
Actual (reported)Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma diagnosis
Ongoing
This is a high risk population of families for NPC
This is a high risk population of families for NPC
National Taiwan University College of Medicine
Taipei, Taiwan, China
Specimens collected: blood and saliva.
Allan Hildesheim, Ph.D.
National Cancer Institute (NCI)
3,795 participants (actual enrollment reported by the registry).
First Submitted
June 19, 2006
First Posted
June 21, 2006
Study Start
November 7, 1995
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
May 31, 2020
Actual (reported)Study Completion
June 5, 2020
Actual (reported)Last Updated
December 11, 2020
Record last verified: 2020-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: